Neurostimulation devices market seen topping $12 billion by 2030

The global neurostimulation devices market is projected to grow from $6.86 billion in 2025 to $7.64 billion in 2026, as demand rises for treatments for chronic neurological conditions and pain. A new Business Research Company report says North America led the market in 2025, while Asia-Pacific ranked second.

Why it matters: - The neurostimulation devices market is expanding as healthcare systems look for more targeted treatments for chronic neurological disorders and pain. - The category is moving toward higher-growth applications, including personalized neuromodulation, minimally invasive devices and home-based therapies. - The report’s forecast suggests the market could become a $12.03 billion business by 2030.

What happened: - The Business Research Company released a report on the global neurostimulation devices market on Aug. 19, 2026. - The report says market size is expected to rise from $6.86 billion in 2025 to $7.64 billion in 2026. - The report forecasts the market will reach $12.03 billion by 2030. - More information is available through a free sample of the report. - The full report is also available online.

The details: - Neurostimulation devices deliver electrical impulses to targeted areas of the nervous system to modulate nerve activity. - The devices are used to interrupt pain signals or stimulate neural pathways to help restore function. - The report ties 2025-2026 growth to rising chronic neurological disorders, broader clinical acceptance of implantable stimulation therapies, expanded pain management protocols, improved diagnosis rates and advanced implant technologies. - The longer-term forecast is supported by demand for personalized neuromodulation treatments, wider use of minimally invasive devices, investment in brain-computer interface research, growth in home-based therapies and more regulatory approvals. - The report highlights closed-loop neurostimulation systems, wireless and miniaturized implants, external non-invasive stimulation devices and long-term therapy customization as major trends. - North America held the largest share of the global market in 2025. - Asia-Pacific ranked second in 2025. - The report also covers South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa. - UK healthcare spending rose 5.6% from 2022 to 2023, compared with 0.9% growth in the prior year, according to the UK Office for National Statistics. - Total UK healthcare expenditure reached about $322.152 billion (£292 billion) in 2023. - The report links broader healthcare spending growth to rising demand for neurostimulation devices. - The report’s expanded 2026 features include market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, and updated graphics and tables.

Between the lines: - The report points to a market that is shifting from basic implantable therapy toward more customizable and connected devices. - Growth in home-based and non-invasive options suggests manufacturers are trying to widen use beyond specialty clinical settings. - The regional ranking shows that North America still anchors demand, but Asia-Pacific is becoming a bigger growth story as access and spending improve.

What's next: - The market’s growth path now depends on whether new neuromodulation formats gain more clinical adoption and regulatory approvals. - Further investment in brain-computer interfaces and closed-loop systems could shape the next phase of product development. - Providers and device makers are likely to keep focusing on personalized treatment models as neurological disease prevalence rises.

The bottom line: - Neurostimulation is moving from a niche therapy area to a faster-growing medtech category with broader global reach and more diverse use cases.